UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disease latency and new‐user versus prevalent‐user cohort designs: Implications for pharmacoepidemiology in dementia

Journal of the American Geriatrics Society (JAGS), 2024-03, Vol.72 (3), p.953-955

2024

Volltextzugriff (PDF)

Reply to: Comment on: Association of sulfonylureas with the risk of dementia: A population‐based cohort study

Journal of the American Geriatrics Society (JAGS), 2024-04, Vol.72 (4), p.1290-1291

2024

Volltextzugriff (PDF)

The complement cascade in Alzheimer’s disease: a systematic review and meta-analysis

Molecular psychiatry, 2021-10, Vol.26 (10), p.5532-5541

2021

Volltextzugriff (PDF)

No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes

Journal of internal medicine, 2024-01, Vol.295 (1), p.68-78

2024

Volltextzugriff (PDF)

Association of sulfonylureas with the risk of dementia: A population-based cohort study

Journal of the American Geriatrics Society (JAGS), 2023-10, Vol.71 (10), p.3059-3070

2023

Volltextzugriff (PDF)

A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease

Journal of neuroinflammation, 2020-03, Vol.17 (1), p.84-11, Article 84

2020

Volltextzugriff (PDF)

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status

Alzheimer's & dementia, 2020-12, Vol.16 (12), p.1663-1673

2020

Volltextzugriff (PDF)

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status

Alzheimer's research & therapy, 2021-02, Vol.13 (1), p.43-15, Article 43

2021

Volltextzugriff (PDF)

Dynamic relationships between depressive symptoms and insulin resistance over 20 years of adulthood

Psychological medicine, 2023-03, Vol.53 (4), p.1458-1467

2023

Volltextzugriff (PDF)

State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease

Alzheimer's & dementia : translational research & clinical interventions, 2023-01, Vol.9 (1), p.e12376-n/a

2023

Volltextzugriff (PDF)

Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid

Ageing research reviews, 2020-09, Vol.62, p.101130, Article 101130

2020

Volltextzugriff (PDF)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia

Alzheimer's research & therapy, 2021-09, Vol.13 (1), p.147-11, Article 147

2021

Volltextzugriff (PDF)

Endosomal-Lysosomal and Autophagy Pathway in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Journal of Alzheimer's disease, 2022-01, Vol.88 (4), p.1279-1292

2022

Volltextzugriff (PDF)

Associations Between Time After Stroke and Exercise Training Outcomes: A Meta-Regression Analysis

Journal of the American Heart Association, 2021-12, Vol.10 (24), p.e022588

2021

Volltextzugriff (PDF)

Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies

Journal of Alzheimer's disease, 2024-01, Vol.100 (4), p.1161-1163

2024

Volltextzugriff (PDF)

Gastric acid suppressants and cognitive decline in people with or without cognitive impairment

Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12243-n/a

2022

Volltextzugriff (PDF)

Diabetes Mellitus Is Associated With Poor In‐Hospital and Long‐Term Outcomes in Young and Midlife Stroke Survivors

Journal of the American Heart Association, 2021-07, Vol.10 (14)

2021

Volltextzugriff (PDF)

Depression interacts with allostatic load to predict cognitive decline in middle age

Psychoneuroendocrinology, 2022-12, Vol.146, p.105922, Article 105922

2022

Volltextzugriff (PDF)

Association of Sodium-Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study

Diabetes care, 2023-02, Vol.46 (2), p.297-304

2023

Volltextzugriff (PDF)

Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis

Brain, behavior, and immunity, 2022-02, Vol.100, p.55-69

2022

Volltextzugriff (PDF)

Timing of sodium-glucose cotransporter 2 inhibitor initiation and post-discharge outcomes in acute heart failure with diabetes: A population-based cohort study

European journal of heart failure, 2024-09

2024

Volltextzugriff (PDF)

Insulin-like growth factor-1 and cognition in normoglycemia, prediabetes, and type 2 diabetes mellitus

Psychoneuroendocrinology, 2024-03, Vol.161, p.106946-106946, Article 106946

2024

Volltextzugriff (PDF)

Glucose-lowering drugs, cognition, and dementia: The clinical evidence

Neuroscience and biobehavioral reviews, 2022-06, Vol.137, p.104654-104654, Article 104654

2022

Volltextzugriff (PDF)

Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers

Neurobiology of aging, 2021-04, Vol.100, p.22-31

2021

Volltextzugriff (PDF)

Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on Aging

Neurology, 2024-05, Vol.102 (9)

2024

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(102)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Disease latency and new‐user versus prevalent‐user cohort designs: Implications for pharmacoepidemiology in dementia

Reply to: Comment on: Association of sulfonylureas with the risk of dementia: A population‐based cohort study

The complement cascade in Alzheimer’s disease: a systematic review and meta-analysis

No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes

Association of sulfonylureas with the risk of dementia: A population-based cohort study

A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status

Dynamic relationships between depressive symptoms and insulin resistance over 20 years of adulthood

State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease

Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia

Endosomal-Lysosomal and Autophagy Pathway in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Associations Between Time After Stroke and Exercise Training Outcomes: A Meta-Regression Analysis

Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies

Gastric acid suppressants and cognitive decline in people with or without cognitive impairment

Diabetes Mellitus Is Associated With Poor In‐Hospital and Long‐Term Outcomes in Young and Midlife Stroke Survivors

Depression interacts with allostatic load to predict cognitive decline in middle age

Association of Sodium-Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study

Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis

Timing of sodium-glucose cotransporter 2 inhibitor initiation and post-discharge outcomes in acute heart failure with diabetes: A population-based cohort study

Insulin-like growth factor-1 and cognition in normoglycemia, prediabetes, and type 2 diabetes mellitus

Glucose-lowering drugs, cognition, and dementia: The clinical evidence

Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers

Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on Aging

Suchergebnisse filtern